Clinical Trial Update: Efficacy/Safety of Rosuvastatin+Ezetimibe in High Risk Patients With Primary Hypercholesterolemia/Mixed Dyslipidemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating rosuvastatin plus ezetimibe in high-risk patients with primary hypercholesterolemia or mixed dyslipidemia has completed with posted res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypercholesterolemia

Drugs mentioned

• Rosuvastatin/Ezetimibe (rosuvastatin; ezetimibe)

Snippet

Sponsor: Ache Laboratorios Farmaceuticos S.A. | Conditions: Hypercholesterolemia, Dyslipidemia | Phase 3 | Status: COMPLETED | Results posted: 2020-01-22